Atea Pharmaceuticals(AVIR)
$4.30+0.09 (+2.14%)
AVIR
Atea Pharmaceuticals stock drug pipeline
$4.30
At close:+0.09 (+2.14%)
Want to see AVIR full AI Analyst Report?
Atea Pharmaceuticals (AVIR) Drug Pipeline
248 Followers
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Atea Pharmaceuticals, Inc. (AVIR) have in its pipeline
Atea Pharmaceuticals AVIR is currently developing the following drugs: Buprenorphine/Naloxone + Bem/Rzr, Methadone +Bem/Rzr, Bemnifosbuvir-Ruzasvir, Sofosbuvir-Velpatasvir, Treatment A-Bemnifosbuvir/Ruzasvir Fdc Administered Fasting, Treatment B-Omeprazole 20 Mg Dose Administered Fasting, Treatment C-Bemnifosbuvir/Ruzasvir Fdc Administered Simultaneously With 20 Mg Dose Of Omeprazole Fasting, Treatment D-Bemnifosbuvir/Ruzasvir Fdc Administered 0.5 Hour Prior To 20 Mg Dose Of Omeprazole, Treatment E-Omeprazole 40 Mg Administered Fasting, Treatment F-Bemnifosbuvir/Ruzasvir Fdc Administered 2 Hours After 40 Mg Dose Omeprazole, Digoxin Vs Digoxin + Bem/Rzr Vs Digoxin + 2H Bem/Rzr, Rosuvastatin Vs Rosuvastatin + Bem/Rzr Vs Rosuvastatin + 2H Bem/Rzr, Bemnifosbuvir/Ruzasvir As A Fixed-Dose Combination, Bemnifosbuvir, Ruzasvir, Bemnifosbuvir. These drug candidates are in various stages of clinical development as the company works toward FDA approval.

